For the quarter ended September 2025, Shell (SHEL) reported revenue of $70.41 billion, down 2.8% over the same period last year. EPS came in at $1.86, compared to $1.92 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $74.85 billion, representing a surprise of -5.94%. The company delivered an EPS surprise of +8.14%, with the consensus EPS estimate being $1.72.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Shell performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:- INTEGRATED GAS - Realised gas price ($/thousand scf): $7.30 versus the three-analyst average estimate of $6.72.
- INTEGRATED GAS - Total production available for sale per day: 934.00 KBOE/D versus the three-analyst average estimate of 937.23 KBOE/D.
- INTEGRATED GAS - LNG liquefaction volumes (MT): 7.30 MTon versus the three-analyst average estimate of 7.08 MTon.
- INTEGRATED GAS - Realised liquids price ($/bbl): $58.00 versus the three-analyst average estimate of $58.66.
- INTEGRATED GAS - Natural gas production available for sale per day: 4,667.00 Mcf/D versus 4,631.53 Mcf/D estimated by three analysts on average.
- INTEGRATED GAS - Liquids production available for sale per day: 130.00 KBOE/D versus the three-analyst average estimate of 138.69 KBOE/D.
- CHEMICALS & PRODUCTS - Global indicative refining margin ($/bbl): $11.60 versus the three-analyst average estimate of $9.70.
- CHEMICALS & PRODUCTS - Refinery utilisation (%): 96% compared to the 93.6% average estimate based on three analysts.
- CHEMICALS & PRODUCTS - Chemicals sales volumes (kT): 2,147.00 KTon versus 3,054.85 KTon estimated by three analysts on average.
- CHEMICALS & PRODUCTS - Refinery processing intake (kb/d): 1,176.00 Kboe/Day versus the three-analyst average estimate of 1,269.71 Kboe/Day.
- UPSTREAM - Total production (kboe/d): 1,832.00 Kboe/Day versus 1,837.28 Kboe/Day estimated by three analysts on average.
- UPSTREAM - Realised liquids price ($/bbl): $64.00 versus the three-analyst average estimate of $58.86.
View all Key Company Metrics for Shell here>>>
Shares of Shell have returned +4.3% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"
Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.
See Our Top Stock to Double (Plus 4 Runners Up) >>Shell PLC Unsponsored ADR (SHEL) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
